XML 20 R8.htm IDEA: XBRL DOCUMENT v3.5.0.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 29, 2016
Jul. 01, 2015
Cash flows from operating activities:    
Net income (loss) $ (1,598) $ 18,267
Adjustments to reconcile net income (loss) to cash flows provided by operating activities:    
Depreciation and amortization 10,598 10,338
Operating (gains), losses and other charges, net 24,116 836
Amortization of deferred financing costs 296 243
(Gain) loss on early extinguishments of debt (52) 266
Deferred income tax expense 5,390 6,300
Share-based compensation 3,850 3,564
Decrease (increase) in assets:    
Receivables 2,455 4,194
Inventories 322 131
Other current assets 7,248 1,012
Other assets (1,113) 271
Increase (decrease) in liabilities:    
Accounts payable (671) (337)
Accrued salaries and vacations (12,730) (4,092)
Accrued taxes 94 (297)
Other accrued liabilities (13,405) (3,136)
Other noncurrent liabilities (1,975) (672)
Net cash flows provided by operating activities 22,825 36,888
Cash flows from investing activities:    
Capital expenditures (7,973) (10,781)
Payments to acquire businesses and real estate 1,476 1,620
Proceeds from disposition of property 1,883 0
Collections on notes receivable 730 974
Issuance of notes receivable (637) (1,000)
Net cash flows used in investing activities (7,473) (12,427)
Cash flows from financing activities:    
Revolver borrowings 30,000 156,500
Revolver payments (27,000) (99,750)
Long-term debt payments (1,555) (56,681)
Proceeds from exercise of stock options 323 401
Tax withholding on share-based payments 0 (982)
Tax benefit for share-based compensation 27 553
Deferred financing costs 0 (1,261)
Purchase of treasury stock (7,764) (21,190)
Net bank overdrafts (4,361) 0
Net cash flows used in financing activities (10,330) (22,410)
Increase in cash and cash equivalents 5,022 2,051
Cash and cash equivalents at beginning of period 1,671 3,074
Cash and cash equivalents at end of period $ 6,693 $ 5,125